Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Biodesix, Inc. - Common Stock (NQ:BDSX)

27.39 +0.76 (+2.85%)

Streaming Delayed Price Updated: 11:51 AM EDT, Sep 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodesix, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Biodesix to Participate in Two Upcoming Investor Conferences in September

September 05, 2023

From Biodesix, Inc.

Via Business Wire

Kingstone Companies And 3 Other Stocks Under $2 Insiders Are Buying ↗

August 24, 2023

The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer

August 22, 2023

From Biodesix, Inc.

Via Business Wire

Recap: Biodesix Q1 Earnings ↗

May 11, 2023

Via Benzinga

Biodesix Earnings Perspective: Return On Capital Employed ↗

March 09, 2023

Via Benzinga

Biodesix Announces Second Quarter 2023 Results and Highlights

August 07, 2023

From Biodesix, Inc.

Via Business Wire

Top 5 Health Care Stocks That May Crash In Q3 ↗

August 07, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference

August 01, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023

July 24, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules

July 12, 2023

From Biodesix, Inc.

Via Business Wire

Why Shares of CareDx Are Jumping Friday ↗

July 07, 2023

The company's diagnostic tests may obtain better coverage from the Centers for Medicare & Medicaid Services.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 06, 2023

Via Benzinga

Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services

July 06, 2023

From Biodesix, Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 06, 2023

It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!

Via InvestorPlace

Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier

June 27, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting

June 01, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference

May 31, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing

May 25, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors

May 24, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference

May 18, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix Announces First Quarter 2023 Results and Highlights

May 11, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023

April 27, 2023

From Biodesix, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 15, 2023

Via Benzinga

Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights

March 06, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference

February 28, 2023

From Biodesix, Inc.

Via Business Wire

Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023

February 21, 2023

From Biodesix, Inc.

Via Business Wire

Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying ↗

February 02, 2023

The Federal Reserve on Wednesday raised its benchmark rate by 0.25%, marking the central bank's second consecutive policy downshift. When insiders purchase or sell shares, it indicates their confidence...

Via Benzinga

Looking Into Biodesix's Recent Short Interest ↗

January 06, 2023

Biodesix's (NASDAQ:BDSX) short percent of float has risen 67.65% since its last report. The company recently reported that it has 347 thousand shares sold short, which is 0.57% of all regular shares...

Via Benzinga

$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying ↗

January 06, 2023

The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test

December 19, 2022

From Biodesix, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Biodesix, Inc. - Common Stock (NQ:BDSX)

All News about Biodesix, Inc. - Common Stock